➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Johnson and Johnson
McKesson
Moodys
Harvard Business School

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,757,394


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,757,394 protect, and when does it expire?

Patent 9,757,394 protects CAROSPIR and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 9,757,394
Title:Spironolactone aqueous formulations
Abstract: Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle.
Inventor(s): Pipho; Anthony (Winterville, NC), DeHart; Michael Paul (Winterville, NC)
Assignee: CMP DEVELOPMENT LLC (Farmville, NC)
Application Number:15/337,559
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,757,394
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Delivery;

Drugs Protected by US Patent 9,757,394

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y CAROSPIR IS INDICATED FOR TREATMENT OF NYHA CLASS III-IV HEART FAILURE AND REDUCED EJECTION FRACTION TO INCREASE SURVIVAL, MANAGE EDEMA, AND TO REDUCE THE NEED FOR HOSPITALIZATION FOR HEART FAILURE ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,757,394

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3003028 ⤷  Free Forever Trial
European Patent Office 3368045 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2017075463 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.